ConductScience.org, home

Paper9109501

Cell cycle and cancer: critical events at the G1 restriction point.

DelSal G and 2 others. Crit Rev Oncog, 1996. Cited by 71 papers, by iCite.

Cite this record

ConductScience Library. Cell cycle and cancer: critical events at the G1 restriction point. Papers, record 9109501. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9109501

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cell cycle and cancer: critical events at the G1 restriction point.
PubMed
Journal
Crit Rev Oncog
PubMed
Year
1996
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
71
iCite
Relative citation ratio, by iCite
1.34
iCite
Revised in PubMed
2019-11-02
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1DelSal GG
2Loda MM
3Pagano MM

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
G1 PhaseMajor topic
NeoplasmsMajor topic
Cyclin-Dependent Kinases
Humans
S Phase

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.

PMIDTitleJournalYearIn PapersSource
30258182The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0/G1 arrest and apoptosis.Cell Death Dis2018https://conductscience.org/library/papers/30258182PubMed
29137415Ubiquitin conjugating enzyme E2 L3 promoted tumor growth of NSCLC through accelerating p27kip1 ubiquitination and degradation.Oncotarget2017https://conductscience.org/library/papers/29137415PubMed
26733491The ascidian natural product eusynstyelamide B is a novel topoisomerase II poison that induces DNA damage and growth arrest in prostate and breast cancer cells.Oncotarget2015https://conductscience.org/library/papers/26733491PubMed
24520316CRIF1 interacting with CDK2 regulates bone marrow microenvironment-induced G0/G1 arrest of leukemia cells.PLoS One2014https://conductscience.org/library/papers/24520316PubMed
24037419Cell adhesion to fibronectin down-regulates the expression of Spy1 and contributes to drug resistance in multiple myeloma cells.Int J Hematol2013https://conductscience.org/library/papers/24037419PubMed
20661828Mixed tocotrienols inhibit prostate carcinogenesis in TRAMP mice.Nutr Cancer2010https://conductscience.org/library/papers/20661828PubMed
15208676ERbeta exerts multiple stimulative effects on human breast carcinoma cells.Oncogene2004https://conductscience.org/library/papers/15208676PubMed
10995786Role of the Cdc25A phosphatase in human breast cancer.J Clin Invest2000https://conductscience.org/library/papers/10995786PubMed
10982843SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1)-->S progression by controlling the expression and cellular compartmentalization of cyclin D.Mol Cell Biol2000https://conductscience.org/library/papers/10982843PubMed
10698498v-Abl utilizes multiple mechanisms to drive G1/S progression in fibroblasts.Oncogene2000https://conductscience.org/library/papers/10698498PubMed
10669755Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription.Mol Cell Biol2000https://conductscience.org/library/papers/10669755PubMed
10665481Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trials.Invest New Drugs1999https://conductscience.org/library/papers/10665481PubMed
10550307p27 expression in inflammatory bowel disease-associated neoplasia. Further evidence of a unique molecular pathogenesis.Am J Pathol1999https://conductscience.org/library/papers/10550307PubMed
10514396Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival.Am J Pathol1999https://conductscience.org/library/papers/10514396PubMed
9736017Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases.Am J Pathol1998https://conductscience.org/library/papers/9736017PubMed
9694794Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression.Genes Dev1998https://conductscience.org/library/papers/9694794PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CHKA1119PubTator's text mininghttps://conductscience.org/library/genes/1119NCBI Gene
PCNA5111PubTator's text mininghttps://conductscience.org/library/genes/5111NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9109501

GET https://conductscience.org/api/papers/v1/9109501/authors